Looking to implement or upgrade Atomwise?
Schedule a Meeting
Drug Discovery

Atomwise

AI-powered drug discovery platform accelerating molecular candidate identification with deep learning

Schedule a Meeting
Category
Software
Ideal For
Pharmaceutical Companies
Deployment
Cloud
Integrations
None+ Apps
Security
Enterprise-grade data security, confidential compound handling, secure data transfer protocols
API Access
Yes - API access for research data integration and workflow automation

About Atomwise

Atomwise is an AI-powered drug discovery platform leveraging deep learning algorithms to predict molecular interactions and accelerate the identification of viable drug candidates. The platform processes vast molecular datasets with exceptional accuracy, significantly reducing the time and cost associated with traditional drug discovery workflows. By automating the screening of millions of potential molecules, Atomwise enables pharmaceutical companies, biotechnology firms, and academic institutions to focus resources on the most promising candidates. The platform's machine learning models are trained on extensive historical data to identify patterns in molecular behavior and drug efficacy. Through AiDOOS marketplace integration, organizations can deploy Atomwise with enterprise-grade governance, scaled computational resources for large-scale molecular screening, and seamless integration with existing R&D infrastructure. This enables faster time-to-IND (Investigational New Drug), reduced preclinical development costs, and improved success rates in early-stage drug candidate selection across therapeutic areas.

Challenges It Solves

  • Traditional drug discovery screening processes are time-consuming and resource-intensive
  • High failure rates and lengthy timelines delay therapeutic breakthroughs
  • Manual molecular candidate evaluation across billions of compounds is inefficient
  • Significant R&D costs associated with synthesizing and testing unsuitable candidates
  • Difficulty identifying optimal lead compounds with desired pharmacological properties

Proven Results

60
Reduction in time to identify promising drug candidates
50
Decrease in preclinical research and development costs
75
Improvement in early-stage candidate success rates

Key Features

Core capabilities at a glance

Deep Learning-Based Molecular Prediction

Advanced neural networks predict molecular interactions with high accuracy

Identifies promising candidates from billions of compounds instantly

Large-Scale Virtual Screening

Process millions of potential molecules in parallel

Screens entire chemical libraries faster than traditional methods

Structure-Activity Relationship Analysis

Understand how molecular structures impact therapeutic effects

Optimize lead compounds with predictive design insights

Multi-Target Drug Design

Discover candidates for complex, multi-target therapeutic challenges

Enable polypharmacology approaches for treatment-resistant conditions

Proprietary AI Model Library

Continuously updated models trained on industry-leading datasets

Access cutting-edge predictive algorithms without model development overhead

Ready to implement Atomwise for your organization?

Schedule a Meeting

Real-World Use Cases

See how organizations drive results

Small Molecule Drug Discovery
Accelerate identification of small molecule candidates for traditional pharmaceutical targets. Rapidly screen chemical libraries to identify compounds with optimal potency and selectivity profiles.
70
Accelerated lead identification by months or years
Oncology and Cancer Research
Discover novel cancer therapeutics by predicting interactions with oncogenic targets. Identify compounds with improved efficacy against resistant mutations.
65
Enhanced success rate in oncology candidate selection
Infectious Disease Drug Development
Rapidly identify antimicrobial and antiviral candidates by screening against pathogenic targets. Support pandemic response and neglected disease therapeutics.
72
Expedited identification of pathogen-targeting compounds
Lead Optimization and Repurposing
Optimize existing lead compounds for improved pharmacokinetics and safety profiles. Discover new therapeutic applications for existing drugs.
58
Enhanced compound properties with computational design
Target Validation and Hit Finding
Validate novel disease targets by identifying tool compounds and chemical probes. Generate high-quality hits for emerging therapeutic targets.
68
Rapid validation of novel therapeutic targets

Integrations

Seamlessly connect with your tech ecosystem

S

Schrödinger Suite

Explore

Integration with computational chemistry tools for enhanced molecular modeling and simulation workflows

C

ChemAxon Marvin

Explore

Seamless chemical structure drawing and property calculation for candidate analysis

G

Gromacs

Explore

Molecular dynamics simulation integration for validating predicted interactions

R

RDKit

Explore

Open-source cheminformatics toolkit integration for molecular fingerprinting and analysis

A

AWS and Cloud Platforms

Explore

Scalable cloud infrastructure integration for massive parallel molecular screening

L

Laboratory Information Management Systems (LIMS)

Explore

ELN/LIMS integration for seamless data flow between prediction and experimental validation

P

PubChem and DrugBank APIs

Explore

Integration with public chemical databases for enhanced training data and validation

Implementation with AiDOOS

Outcome-based delivery with expert support

Outcome-Based

Pay for results, not hours

Milestone-Driven

Clear deliverables at each phase

Expert Network

Access to certified specialists

Implementation Timeline

1
Discover
Requirements & assessment
2
Integrate
Setup & data migration
3
Validate
Testing & security audit
4
Rollout
Deployment & training
5
Optimize
Performance tuning

See how it works for your team

Schedule a Meeting

Alternatives & Comparisons

Find the right fit for your needs

Capability Atomwise Benchling
Customization Excellent Excellent
Ease of Use Good Good
Enterprise Features Excellent Excellent
Pricing Fair Fair
Integration Ecosystem Good Good
Mobile Experience Fair Fair
AI & Analytics Excellent Good
Quick Setup Good Good

Similar Products

Explore related solutions

Benchling

Benchling

Benchling is a cloud-based platform designed to streamline research and development (R&D) in the li…

Explore

Frequently Asked Questions

How does Atomwise compare to traditional molecular docking software?
Atomwise uses deep learning to learn from historical data, enabling superior accuracy and speed compared to physics-based docking. It processes millions of compounds in hours versus days with traditional methods, significantly accelerating lead identification.
Can Atomwise be integrated into existing drug discovery workflows?
Yes. Atomwise offers API access and integrations with leading LIMS, ELN, and computational chemistry platforms. Through AiDOOS, we provide managed deployment ensuring seamless integration with your existing R&D infrastructure and governance requirements.
What types of therapeutic targets does Atomwise support?
Atomwise supports diverse target classes including proteins, enzymes, ion channels, and GPCRs. The platform's machine learning models are continuously trained on expanded datasets to support emerging and novel therapeutic targets.
How does data security work for proprietary compounds?
Atomwise implements enterprise-grade security with end-to-end encryption, confidential compound handling, and audit logging. Organizations retain complete control over their intellectual property, and all data transfer is secured through encrypted protocols.
What is the timeline for identifying drug candidates using Atomwise?
Virtual screening timelines are dramatically reduced—millions of compounds can be screened within hours or days. This enables organizations to accelerate time-to-lead by months, though validation through experimental testing remains essential.
How does AiDOOS enhance Atomwise deployment?
AiDOOS provides managed cloud deployment, enterprise governance, automated scaling for large screening campaigns, and seamless integration with your R&D ecosystem—enabling faster time-to-value and reduced deployment complexity.